The SMR Anatomic Shoulder System is indicated for partial or total, primary or revision shoulder joint replacement in patients suffering from disability due to:

non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis;
inflammatory degenerative joint disease such as rheumatoid arthritis;
treatment of acute fractures of the humeral head that cannot be treated with other fracture fixation methods;
revision of a failed primary implant;
cuff tear arthropathy (CTA Heads only);
glenoid arthrosis without excessive glenoid bone loss: A1, A2 and B1 according to Walch classification (SMR TT Hybrid Glenoid only).

The SMR Reverse Shoulder System is indicated for primary, fracture or revision total shoulder cuff deficient joint with severe arthropathy (disabled shoulder). The patient's joint must be anatomically suited to receive the selected implants and a functional deltoid muscle is necessary to use the device.

The SMR TT Hybrid Glenoid Reverse Baseplate must not be used in cases of excessive glenoid bone graft is needed.

The Modular SMR Shoulder System allows the assembly of components in various humeral and glenoid constructs are intended for cemented and uncemented use as specified in the following table.

Device Description

The SMR TT Augmented Glenoid System is a modular system intended to be used in combination with previously cleared components of the SMR Reverse Shoulder System. The system consists of a modular glenoid component to be used in total shoulder replacement in a reverse shoulder configuration. The glenoid component consists of a metal back glenoid (named SMR TT Augmented 360 Baseplate), coupled to a peg made of Trabecular Titanium. The glenoid component is intended for uncemented use with the addition of bone screws for fixation to the bone.

AI/ML Overview

The provided text is related to a 510(k) premarket notification for the "SMR TT Augmented Glenoid System," a medical device for shoulder joint replacement. This document primarily focuses on demonstrating substantial equivalence to predicate devices through design, materials, intended use, and non-clinical mechanical testing.

Crucially, the document explicitly states: "Clinical testing was not necessary to demonstrate substantial equivalence of the SMR TT Augmented Glenoid System to the predicate devices."

This means that the device's acceptance criteria were not proven through a clinical study involving human patients, nor through a performance study that would typically involve test sets, expert ground truth, or MRMC studies for an AI/CAD type of device. The acceptance criteria and proof of their fulfillment are based on equivalence to predicate devices and mechanical testing of the device components.

Therefore, for the specific questions you've asked, the information is largely not applicable or not present in the provided text, as this device's clearance was based on non-clinical data.

Here's a breakdown of the requested information based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Since clinical testing for device performance in the context of AI/CAD (e.g., diagnostic accuracy) was not conducted or deemed necessary, the acceptance criteria and performance relate to mechanical integrity and material properties.

Acceptance Criteria	Reported Device Performance
Mechanical Testing:
Torsional strength for bone screws (ASTM F543)	Device performed substantially equivalent to predicate devices.
Driving torque for bone screws (ASTM F543)	Device performed substantially equivalent to predicate devices.
Pull-out strength for bone screws (ASTM F543)	Device performed substantially equivalent to predicate devices.
Dynamic Evaluation of Glenoid Loosening or Disassociation (ASTM F2028)	Device performed substantially equivalent to predicate devices.
Fatigue Fretting test on Glenoid Baseplate in reverse shoulder configuration	Device performed substantially equivalent to predicate devices.
Range of Motion (ASTM F1378)	Device performed substantially equivalent to predicate devices.
Material Standards:
Ti6Al4V (ISO 5832-3 - ASTM F1472)	Conforms to standard.
CoCrMo (ISO 5832-12 - ASTM F1537)	Conforms to standard.
UHMWPE (ISO 5834-2 - ASTM F648)	Conforms to standard.
PoroTi Titanium Coating (ASTM F1580)	Conforms to standard.
Ta (ISO13782 - ASTM F560)	Conforms to standard.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Not Applicable. No clinical test set involving human data was used for performance evaluation as "Clinical testing was not necessary." The evaluation was based on mechanical testing of the device components. The specifics of the mechanical test samples are not detailed beyond referencing ASTM standards.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not Applicable. As no clinical "test set" in the context of diagnostic accuracy was used, no human experts were involved in establishing ground truth for such a purpose.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not Applicable. Since no test set requiring expert interpretation was used, no adjudication method was employed.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not Applicable. No MRMC study was conducted. This device is a surgically implanted prosthetic, not an AI/CAD system assisting human readers with interpreting medical images.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not Applicable. This device is a physical implant, not an algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

The "ground truth" for this device, in terms of demonstrating safety and effectiveness, was established through adherence to material standards and performance against specified mechanical testing standards (e.g., ASTM F543, ASTM F2028, ASTM F1378). The comparative aspect was based on substantial equivalence to legally marketed predicate devices in terms of intended use, design, and materials.

8. The sample size for the training set

Not Applicable. This is not an AI/ML device, so there is no "training set."

9. How the ground truth for the training set was established

Not Applicable. This is not an AI/ML device, so there is no "training set" or associated ground truth for a training set.

Summary

{0}------------------------------------------------

November 22, 2019

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Limacorporate S.p.A % Stephen Peoples President Peoples & Associates Consulting LLC 5010 Lodge Pole Lane Fort Wayne, Indiana 46814

Re: K191746

Trade/Device Name: SMR TT Augmented Glenoid System Regulation Number: 21 CFR 888.3660 Regulation Name: Shoulder joint metal/polymer semi-constrained cemented prosthesis Regulatory Class: Class II Product Code: PHX, KWS, KWT, MBF Dated: October 18, 2019 Received: October 21, 2019

Dear Stephen Peoples:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for

{1}------------------------------------------------

devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Michael C. Owens Acting Assistant Director DHT6A: Division of Joint Arthroplasty Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

510(k) Number (if known) K191746

Device Name

SMR TT Augmented Glenoid System

Indications for Use (Describe)

The SMR Shoulder System is intended for partial or total, primary or revision shoulder joint replacement.

The SMR Anatomic Shoulder System is indicated for partial or total, primary or revision shoulder joint replacement in patients suffering from disability due to:

non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis;
inflammatory degenerative joint disease such as rheumatoid arthritis; ●
treatment of acute fractures of the humeral head that cannot be treated with other fracture fixation methods; .
. revision of a failed primary implant;
. cuff tear arthropathy (CTA Heads only);
glenoid arthrosis without excessive glenoid bone loss: A1, A2 and B1 according to Walch classification (SMR TT Hybrid Glenoid . only).

The SMR TT Hybrid Glenoid Reverse Baseplate must not be used in cases of excessive glenoid bone graft is needed.

The Modular SMR Shoulder System allows the assembly of components in various humeral and glenoid constructs are intended for cemented and uncemented use as specified in the following table.

In the Anatomic shoulder the humeral consists of the humeral body, the adaptor taper and the humeral head. In the Reverse shoulder the humeral consists of the humeral stem, the reverse humeral body and the reverse liner. On the humeral side the fixation of the humeral stem determines if the construct is cemented or uncemented.

The Anatomic glenoid construct consists of an all polyethylene glenoid with metal peg or a metal back assembled with a liner; the Reverse glenoid connector/glenosphere construct or of a peg/baseplate/glenosphere construct.

On the glenoid side, the fixation of the all polyethylene glenoid with metal peg or the metal back determines if the construct is cemented or uncemented.

System		Components	Material	Use
A	R			Cem	NotCem
•	•	SMR Stems (Cemented, Cemented Revision)	Ti6Al4V	X
•	•	SMR Stems (Cementless Finned, Cementless Revision)	Ti6Al4V		X
•	•	SMR Humeral Bodies (Trauma, Finned)	Ti6Al4V	X	X
•	•	SMR Reverse Humeral Body	Ti6Al4V	X	X
•	•	Humeral Extension	Ti6Al4V	X	X
•	•	SMR Humeral Heads (Standard*, CTA)	CoCrMo	X	X
•	•	SMR Adaptor Tapers (Neutral, Eccentric)	Ti6Al4V	X	X
•	•	SMR CTA Head Adaptor for Reverse Humeral Body	Ti6Al4V	X	X

FORM FDA 3881 (7/17)

PSC Publishing Services (301) 443-6740

{3}------------------------------------------------

System		Components	Material	Use
A	R			Cem	NotCem
	•	SMR Glenospheres	CoCrMo		X
	•	SMR Connectors*	Ti6Al4V		X
	•	Reverse Liners	UHMWPE	X	X
•		SMR Cemented Glenoids	UHMWPE	X
•		SMR 3 Pegs Cemented Glenoids	UHMWPE	X
•	• *	SMR TT Hybrid Glenoid	UHMWPE+Ti6Al4V+Ta	X	X
	•	SMR TT Hybrid Glenoid Reverse Baseplate + Screw	Ti6Al4V		X
•	•	SMR Metal Back Glenoids	Ti6Al4V+PoroTi	X*	X*
•	•	SMR TT Baseplate	Ti6Al4V	X*	X*
	•	SMR TT Augmented 360 Baseplate	Ti6Al4V		X
•	•	SMR TT Glenoid Peg	Ti6Al4V	X	X
•		SMR Metal Back Liner	UHMWPE	X*	X*
• *	•	SMR Bone screws	Ti6Al4V		X
Material Standards
Ti6Al4V (ISO 5832-3 - ASTM F1472) - CoCrMo (ISO 5832-12 - ASTM F1537) – UHMWPE (ISO 5834-2 - ASTM F648) -
PoroTi Titanium Coating (ASTM F1580) - Ta (ISO13782 - ASTM F560)

A= Anatomic / R=Reverse

*NOTE:

In the US, the SMR Metal Backed Glenoid/Liner construct, used as part of the SMR Anatomic Shoulder Replacement, is intended . for use with bone cement and should be used without bone screws.
. The SMR Metal Backed Glenoid/Connector/Glenosphere construct, used as part of the SMR Reverse Shoulder replacement, is intended for uncemented use with the addition of screws for fixation.
SMR Lateralized Connectors are not indicated for use with glenoid bone grafting techniques. �
In the US the SMR TT Metal Back Baseplate used as part of the SMR Anatomic Shoulder Replacement, is intended for use with bone cement and should be used without bone screws, while when used as part of the SMR Reverse Shoulder replacement, is intended for uncemented use with the addition of screws for fixation.
If a SMR TT Hybrid Glenoid is in place and revision to a reverse prosthesis is required, the patient can be revised by removing ® the polyethylene baseplate, leaving the metal peg in place and by connecting it to the SMR TT Hybrid Glenoid Reverse Baseplate. The SMR TT Hybrid Glenoid Reverse Baseplate is intended for uncemented use with the addition of screws for fixation.
The Dia. 50, 52 and 54mm Humeral Heads with + 3mm increased height cannot be coupled to the Long Adaptor Tapers (both ● concentric and eccentric). The Dia. 52 and 54mm Humeral Heads with +2mm increased height cannot be coupled to the Long Adaptor Tapers (both concentric and eccentric).

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

{4}------------------------------------------------

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{5}------------------------------------------------

Summary of Safety and Effectiveness

Date: November 22, 2019

Manufacturer: Limacorporate S.p.A. Via Nazionale, 52 33038 - Villanova di San Daniele Udine - Italy

U.S. Contact Person: Dr. Stephen J. Peoples Principal Consultant Phone: 260-645-0327 FAX: +39 0432945512

Product	Product Code	Regulation and Classification Name
SMR TTAugmentedGlenoid System	MBF	Shoulder joint metal/polymer/metalnonconstrained or semi-constrained porous-coated uncemented prosthesis per 21 CFR888.3670
	KWS	Shoulder joint metal/polymer semi-constrainedcemented prosthesis per 21 CFR 888.3660
	KWT	Shoulder joint metal/polymer non-constrainedcemented prosthesis per 21 CFR 888.3650
	PHX	Shoulder joint metal/polymer semi-constrainedcemented prosthesis per 21 CFR 888.3660

Description:

Intended Use:

The SMR Shoulder System is intended for partial or total, primary or revision shoulder joint replacement.

The SMR Anatomic Shoulder System is indicated for partial or total, primary or revision shoulder joint replacement in patients suffering from disability due to:

non-inflammatory degenerative ioint disease including osteoarthritis and avascular . necrosis;
inflammatory degenerative joint disease such as rheumatoid arthritis;
treatment of acute fractures of the humeral head that cannot be treated with other ● fracture fixation methods;
revision of a failed primary implant; ●

Traditional 510(k) – SMR TT Augmented Glenoid System November 22, 2019

{6}------------------------------------------------

cuff tear arthropathy (CTA Heads only);
glenoid arthrosis without excessive glenoid bone loss: A1, A2 and B1 according to ● Walch classification (SMR TT Hybrid Glenoid only).

The SMR Reverse Shoulder System is indicated for primary, fracture or revision total shoulder replacement in a grossly rotator cuff deficient joint with severe arthropathy (disabled shoulder). The patient's joint must be anatomically and structurally suited to receive the selected implants and a functional deltoid muscle is necessary to use the device.

The SMR TT Hybrid Glenoid Reverse Baseplate must not be used in cases of excessive glenoid bone loss and/or when bone graft is needed.

The Modular SMR Shoulder System allows the assembly of components in various humeral and glenoid constructs. The constructs are intended for cemented and uncemented use as specified in the following table.

In the Anatomic shoulder the humeral construct consists of the humeral stem, the humeral body, the adaptor taper and the humeral head. In the Reverse shoulder the humeral construct consists of the humeral stem, the reverse humeral body and the reverse liner. On the humeral side the fixation of the humeral stem determines if the construct is cemented or uncemented.

The Anatomic glenoid construct consists of an all polyethylene glenoid, a polyethylene glenoid with metal peg or a metal back assembled with a liner; the Reverse glenoid consists a peg/baseplate/glenosphere construct.

On the glenoid side, the fixation of the all polyethylene glenoid, the polyethylene glenoid with metal peg or the metal back determines if the construct is cemented or uncemented.

System				Use
A	R	Components	Material	Cem	NotCem
●	●	SMR Stems (Cemented, Cemented Revision)	Ti6Al4V	X
●	●	SMR Stems (Cementless Finned, Cementless Revision)	Ti6Al4V		X
●		SMR Humeral Bodies (Trauma, Finned)	Ti6Al4V	X	X
●	●	SMR Reverse Humeral Body	Ti6Al4V	X	X
●	●	Humeral Extension	Ti6Al4V	X	X
●		SMR Humeral Heads (Standard*, CTA)	CoCrMo	X	X
●		SMR Adaptor Tapers (Neutral, Eccentric)	Ti6Al4V	X	X
●		SMR CTA Head Adaptor for Reverse Humeral Body	Ti6Al4V	X	X
	●	SMR Glenospheres	CoCrMo		X
	●	SMR Connectors*	Ti6Al4V		X
	●	Reverse Liners	UHMWPE	X	X
●		SMR Cemented Glenoids	UHMWPE	X
●		SMR 3 Pegs Cemented Glenoids	UHMWPE	X
●	● *	SMR TT Hybrid Glenoid	UHMWPE+Ti6Al4V+Ta	X	X
	●	SMR TT Hybrid Glenoid Reverse Baseplate + Screw	Ti6Al4V		X
●	●	SMR Metal Back Glenoids	Ti6Al4V+PoroTi	X*	X*
●	●	SMR TT Baseplate	Ti6Al4V	X*	X*

Traditional 510(k) - SMR TT Augmented Glenoid System November 22, 2019

{7}------------------------------------------------

System				Use
A	R	Components	Material	Cem	NotCem
	●	SMR TT Augmented 360 Baseplate	Ti6Al4V		X
●	●	SMR TT Glenoid Peg	Ti6Al4V	X	X
●	●	SMR Metal Back Liner	UHMWPE	X*	X*
● *	●	SMR Bone screws	Ti6Al4V		X
Material Standards
Ti6Al4V (ISO 5832-3 - ASTM F1472) - CoCrMo (ISO 5832-12 - ASTM F1537) – UHMWPE (ISO 5834-2 - ASTM F648) - PoroTi Titanium Coating (ASTM F1580) - Ta (ISO13782 - ASTM F560)

A= Anatomic / R=Reverse

*NOTE:

In the US, the SMR Metal Backed Glenoid/Liner construct, used as part of the ● SMR Anatomic Shoulder Replacement, is intended for use with bone cement and should be used without bone screws.
The SMR Metal Backed Glenoid/Connector/Glenosphere construct, used as part ● of the SMR Reverse Shoulder replacement, is intended for uncemented use with the addition of screws for fixation.
SMR Lateralized Connectors are not indicated for use with glenoid bone ● grafting techniques.
In the US the SMR TT Metal Back Baseplate used as part of the SMR Anatomic Shoulder Replacement, is intended for use with bone cement and should be used without bone screws; while when used as part of the SMR Reverse Shoulder replacement, is intended for uncemented use with the addition of screws for fixation.
If a SMR TT Hybrid Glenoid is in place and revision to a reverse prosthesis is . required, the patient can be revised by removing the polyethylene baseplate, leaving the metal peg in place and by connecting it to the SMR TT Hybrid Glenoid Reverse Baseplate. The SMR TT Hybrid Glenoid Reverse Baseplate is intended for uncemented use with the addition of screws for fixation.
The Dia. 50, 52 and 54mm Humeral Heads with + 3mm increased height cannot ● coupled to the Long Adaptor Tapers (both concentric and eccentric). The be Dia. 52 and 54mm Humeral Heads with + 2mm increased height cannot be coupled to the Long Adaptor Tapers (both concentric and eccentric).

Predicate Devices:

SMR TT Metal Back Glenoid (Limacorporate, K133349)
Aequalis PerFORM and PerFORM+ Reversed Glenoids (Tornier Inc., K161742) ●
Comprehensive Augmented Glenoid (Biomet Manufacturing Corp, K172502) ●

Summary of technology comparison:

The intended use, design, and materials of the SMR TT Augmented Glenoid System are substantially equivalent to the ones of the predicate devices. Design Control Activities have been completed and the results indicated that the subject device is safe and effective.

Traditional 510(k) - SMR TT Augmented Glenoid System November 22, 2019

{8}------------------------------------------------

Non-clinical testing

Mechanical testing had demonstrated the device's ability to perform substantially equivalent to the predicate devices in:

. Torsional test, driving torque test, pull-out test for bone screws (ASTM F543);
Dynamic Evaluation of the Glenoid Loosening or Disassociation (ASTM F2028); ●
Fatigue Fretting test on Glenoid Baseplate in reverse shoulder configuration; .
Range of motion (ASTM F1378). .

Clinical testing

Clinical testing was not necessary to demonstrate substantial equivalence of the SMR TT Augmented Glenoid System to the predicate devices.

K191746 Page 4 of 4

Regulation Number and Section

§ 888.3660 Shoulder joint metal/polymer semi-constrained cemented prosthesis.

(a)
Identification. A shoulder joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral resurfacing component made of alloys, such as cobalt-chromium-molybdenum, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II. The special controls for this device are:(1) FDA's:
(i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ”
(ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”
(iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,”
(iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and
(v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,”
(2) International Organization for Standardization's (ISO):
(i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,”
(ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,”
(iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,”
(iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,”
(v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,”
(vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and
(vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and
(3) American Society for Testing and Materials':
(i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,”
(ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,”
(iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,”
(iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,”
(v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,”
(vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,”
(vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and
(viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”